drugset / Trial / NCT01703078
Safety and Tolerability of Different Concentrations of an Ingenol Derivative Field Therapy in the Treatment of Actinic Keratosis
RandomizedSingle-groupSingle-blindTreatment
Summary
The purpose of this study is to determine if the new ingenol derivative gels are as safe as and as well tolerated as ingenol mebutate gel when applied to AK lesions on the forearm for two consecutive days.
Timeline
- Start
- 2012-11
- Primary completion
- 2013-03
- Completion
- 2013-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ingenol | Small molecule | 0.05 % | Topical |